Perseris
Product Images NDC 12496-0120

Product Visual Gallery

This gallery contains 37 technical images submitted to the FDA as part of the official labeling for Perseris (NDC 12496-0120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indivior Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Per0b 0012 01

PERSERIS carton packaging label by Indivior Inc. The box shows the brand name prominently with design elements on a light-colored background. No specific strength or dosage form details are visible on the packaging in the image.*

FDA Label Image

Per0b 0012 02

FDA Label Image

Per0b 0012 03

Illustration showing three components: a liquid syringe, a powder syringe, and a needle with needle guard. The liquid and powder syringes are depicted with different labels and designs, alongside a separate needle packaged in a protective wrapper. The image likely relates to the assembly or components of the PERSERIS injection product by Indivior Inc.*

FDA Label Image

Per0b 0012 04

An instructional illustration depicting a person holding a syringe with one hand and preparing to remove or adjust a part labeled 'P' near the syringe's cap or plunger with the other hand. The image shows the fingers positioned to grasp the labeled component, likely indicating a step in medication preparation or administration.*

FDA Label Image

Per0b 0012 05

An instructional diagram showing hands manipulating two syringe-like devices. The image includes arrows indicating directions for twisting or removing a cap or cover on one of the devices, suggesting steps for preparing or handling the product. The illustration is related to the administration or preparation process of PERSERIS by Indivior Inc.*

FDA Label Image

Per0b 0012 06

An instructional illustration showing hands preparing a syringe for injection. One hand holds the syringe barrel, while the other hand adjusts the plunger. Labels 'L' and 'P' indicate parts of the syringe involved in the preparation process, suggesting step-by-step guidance for proper use.*

FDA Label Image

Per0b 0012 07

Illustration showing the correct method to rotate the PERSERIS injection syringe in both directions with hands holding it. The lower panel indicates that one complete cycle equals rotating back and forth once.*

FDA Label Image

Per0b 0012 08

An instructional illustration showing two-step handling of a syringe. The first step depicts holding the syringe barrel labeled 'L' while pressing the plunger labeled 'P' downwards. The second step shows a twisting motion of the plunger 'P' relative to the syringe barrel 'L'. This image is related to the PERSERIS product by Indivior Inc.*

FDA Label Image

Per0b 0012 09

An anatomical diagram showing the location of the Transpyloric and Transtubercular planes on the human torso. It highlights a central shaded area divided into four numbered quadrants (1 to 4), illustrating abdominal regions relevant for medical or anatomical reference.*

FDA Label Image

Per0b 0012 10

An instructional illustration showing a syringe with a needle being inserted into a vial or cartridge, demonstrating the preparation or drawing of medication. The image shows the syringe barrel, plunger, and needle in a clear, simple line drawing style.*

FDA Label Image

Per0b 0012 11

An instructional illustration showing a hand pressing or inspecting the upper arm of a person, possibly demonstrating an injection or examination procedure related to the product PERSERIS by Indivior Inc.*

FDA Label Image

Per0b 0012 12

An instructional illustration showing two hands preparing an injection at a 45-degree angle into a patient's arm. One hand holds a syringe with a needle, positioned ready to inject, while the other hand stabilizes the area for injection. This diagram likely demonstrates proper injection technique.*

FDA Label Image

Per0b 0012 13

An instructional illustration showing a healthcare professional administering an injection into the upper arm of a patient. The image depicts the positioning of one hand on the injection site and the other hand holding a syringe inserted into the skin, demonstrating the intramuscular injection technique.*

FDA Label Image

Per0b 0012 14

An instructional illustration showing a hand holding a syringe with a needle attached, positioned above a surface with an arrow indicating a counterclockwise rotation motion. The image demonstrates part of the process of preparing or using the injection device associated with PERSERIS by Indivior Inc.*

FDA Label Image

Per0b 0012 15

FDA Label Image

Per0b 0012 16

Chemical structure of the active ingredient in PERSERIS, showing a complex organic molecule with multiple nitrogen atoms, a fluorinated aromatic ring, and several cyclic rings.*

FDA Label Image

Per0b 0012 17

A line graph showing the least square mean change with standard error over days 1, 15, 29, 43, and 57 in three groups: PERSERIS 90 mg, PERSERIS 120 mg, and placebo. The graph includes a table presenting the number of patients for each group at each visit day. The PERSERIS 120 mg group shows the greatest decrease over time, followed by the 90 mg group, with placebo showing the least decrease.*

FDA Label Image

Per0b 0012 18

PERSERIS 90 mg (risperidone) extended-release injectable suspension carton label by Indivior Inc. The packaging shows a single-dose syringe kit for abdominal subcutaneous injection only. It includes dosage instructions, storage conditions, and kit contents details.*

FDA Label Image

Per0b 0012 19

Label for PERSERIS (risperidone) 90 mg, a once-monthly extended-release injectable suspension. The label shows a powdered syringe image, designates the product for abdominal subcutaneous injection only, and includes dosing preparation instructions. Labeler is Indivior Inc., with manufacturing details by Patheon Mfr. Services.*

FDA Label Image

Per0b 0012 20

Delivery system label for PERSERIS 90 mg by Indivior Inc. It is a single-dose, sterile liquid syringe designed for abdominal subcutaneous injection. The label includes mixing instructions for the syringe contents and powder, and manufacturing details from Indivior Inc., North Chesterfield, VA, and AMRI Global, Burlington, MA.*

FDA Label Image

Per0b 0012 21

PERSERIS 90 mg label for risperidone, indicating it is for abdominal subcutaneous injection only. The label shows it is a powder syringe, sterile, prescription-only product from Indivior Inc., with space for lot and expiration date information. It also notes an unvarnished area intended for wrapping.*

FDA Label Image

Per0b 0012 22

Packaging label for PERSERIS 90 mg delivery system by Indivior Inc., designed for abdominal subcutaneous injection. The label indicates a liquid syringe, sterile condition, Rx only, with space for lot and expiration dates. It includes instructions noting unvarnished area for wrap and manufactured by AMRI Global.*

FDA Label Image

Per0b 0012 23

PERSERIS 120 mg injectable suspension packaging label shows it is a once-monthly extended-release risperidone injection for abdominal subcutaneous use. The label includes kit contents of two pouches and one needle, instructions for mixing powder and liquid syringes, and storage directions. Labeler is Indivior Inc.*

FDA Label Image

Per0b 0012 24

PERSERIS 120 mg prefilled syringe label showing risperidone for extended-release injectable suspension. The label indicates a single-dose, sterile product for abdominal subcutaneous injection, with instructions to read full prescribing information. Manufactured for Indivior Inc., North Chesterfield, VA.*

FDA Label Image

Per0b 0012 25

Packaging label for PERSERIS 120 mg delivery system by Indivior Inc. The label indicates it is a sterile, single-dose only liquid syringe designed for abdominal subcutaneous injection. It includes instructions to read full prescribing information and details about the pouch contents consisting of inactive ingredients for mixing prior to use.*

FDA Label Image

Per0b 0012 26

Label for PERSERIS 120 mg (risperidone) powder syringe, indicated for abdominal subcutaneous injection only. The label includes NDC 12496-0120-5, is marked Rx only and sterile, and notes manufacturing by Patheon Mfr. Services. It also has placeholders for lot number and expiration date and specifies an unvarnished area for wrap.*

FDA Label Image

Per0b 0012 27

Label for the PERSERIS 120 mg delivery system by Indivior Inc., designed for abdominal subcutaneous injection. The label indicates it is a sterile liquid syringe for prescription use only, includes a lot and expiration date area, and is manufactured by AMRI Global.*

FDA Label Image

Per0b 0012 28

Packaging label for PERSERIS (risperidone) 90 mg extended-release injectable suspension by Indivior Inc. The label specifies it as a once-monthly injection for abdominal subcutaneous use, including kit contents and mixing instructions with powder and liquid syringes. The package also notes it is a single-dose, sterile product and includes storage and handling details.*

FDA Label Image

Per0b 0012 29

PERSERIS 90 mg injectable suspension packaging label by Indivior Inc. for extended-release risperidone. Once-monthly, single-dose, sterile prefilled syringe for abdominal subcutaneous injection. Label includes instructions to read full prescribing information before use and states the product is Rx only. Pouch contents and manufacturer details are also visible.*

FDA Label Image

Per0b 0012 30

Label for PERSERIS 90 mg delivery system by Indivior Inc. This label specifies the product is for abdominal subcutaneous injection only, with instructions to see complete directions and full prescribing information. The label includes a syringe illustration and notes the product is a sample, not for sale. Manufacturing details and revision date July 2018 are also visible.*

FDA Label Image

Per0b 0012 31

PERSERIS 90 mg (risperidone) powder syringe label for abdominal subcutaneous injection. The label indicates it is sterile, Rx only, and includes a sample designation. Manufactured by Indivior Inc.*

FDA Label Image

Per0b 0012 32

Label for PERSERIS 90 mg delivery system by Indivior Inc., showing it as a sterile liquid syringe for abdominal subcutaneous injection. The label includes the NDC 12496-0589-7, Rx only, and denotes this as a sample.*

FDA Label Image

Per0b 0012 33

PERSERIS 120 mg once-monthly extended-release injectable suspension (risperidone) packaging label. The label shows it is for abdominal subcutaneous injection only, and is a single-dose kit containing liquid and powder syringes. The labeler is Indivior Inc. Instructions and storage details are also visible.*

FDA Label Image

Per0b 0012 34

The image shows a PERSERIS 120 mg packaging label for extended-release injectable suspension. It includes prescribing details for abdominal subcutaneous injection and instructions to read the prescribing information. The label features a syringe illustration and indicates the product is sterile, single-dose, and Rx only. Manufactured by Indivior Inc.*

FDA Label Image

Per0b 0012 35

PERSERIS 120 mg delivery system label for abdominal subcutaneous injection. The single-dose syringe is prefilled with inactive ingredients, designed to deliver 0.8 mL. The label includes usage instructions, a diagram of the syringe, and manufacturer details for Indivior Inc., North Chesterfield, VA, with a revision date of July 2018.*

FDA Label Image

Per0b 0012 36

PERSERIS 120 mg powder syringe label showing risperidone as the active ingredient for abdominal subcutaneous injection. The label includes the NDC number 12496-0120-7, indicates the product is sterile and prescription-only, with manufacturing credited to Patheon Mfr. Services and labeling by Indivior Inc.*

FDA Label Image

Per0b 0012 37

Label for PERSERIS 120 mg delivery system, consisting of a liquid syringe for abdominal subcutaneous injection. The label includes NDC number 12496-0776-7 and indicates that the product is sterile and prescription only. Manufactured by AMRI Global and labeled as a sample.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.